Skip to main content
. 2021 Sep 18;49(3):871–880. doi: 10.1007/s00259-021-05554-2

Fig. 6.

Fig. 6

Histological changes evaluated by hematoxylin and eosin staining in a the tumour and b the kidney at day 44 after the administration of [177Lu]FAPI-46, and c the kidney at day 32 after the administration of [225Ac]FAPI-46. No significant difference was observed both in the tumour and the kidney compared to controls. Yellow bar indicates 50 μm